Rheumatoid Arthritis HLA Association
Use
Rheumatoid arthritis (RA) is a chronic autoimmune disease that primarily affects the joints. Worldwide, the pervalence ranges between 0.5 to 1 percent and genetic factors play a role in RA risk, severity, and progression. The most important gene conferring risk for Anti-Citrullinated Protein Antibody positive (ACPA+) RA resides in the class II major histocompatibility complex (MHC) at the HLA-DRB1 locus. The HLA-DRB1 alleles that predispose to RA are the DRB1*04:01, *04:04, *04:05, *04:08, *01:01, *01:02, *09:01, *10:01 and *14:02 alleles, most of which possess a shared epitope (SE). These alleles increase the risk of RA in all populations, but the degree of predisposition may vary with different populations.
Special Instructions
If you have questions, please call 800-533-1037 (HLA customer service) for assistance selecting the proper HLA test for the patient.
Limitations
This test was developed and its performance characteristics were determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration, meaning its results should be interpreted in the context of clinical findings and not solely used to make a diagnosis. A negative result for the RA-associated DRB1 alleles does not preclude a diagnosis of RA in the individual tested. Testing schedules may vary, and in some cases, additional time should be allowed for reflex tests.
Methodology
NGS (Targeted)
Biomarkers
LOINC Codes
- 57298-2
- 49549-9
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
7 mL
Minimum Volume
3 mL
Container
Lavender-top (EDTA) tube
Storage Instructions
Maintain specimen at ambient temperature; protect from extreme heat or cold. Do not freeze.
Causes for Rejection
Hemolyzed; clotted specimen
